India’s Precision Medicine: A Vision Hindered by Biobank Regulations

Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.

Organ-on-chip device Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.

The Promise of Precision Medicine

In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.

India’s Growing Market

The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.

The Biobank Conundrum

Biobank While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.

A Path Forward

To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.

Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

How AI Is Transforming Financial Advisors’ Daily Routines in 2026

In 2026, financial advisors are no longer just experimenting with AI — they’re relying on it. Once confined to back-office duties, AI now supports meeting prep, portfolio analysis, and even early-stage financial planning. Advisors say the tech is strengthening client relationships by freeing them from administrative overload, though entry-level roles like paraplanners may feel the squeeze as automation accelerates.

AI Is Outpacing the Mortgage Industry’s Cyber Defenses as Attacks Surge

Cybercriminals are weaponizing AI to launch highly convincing email scams and system breaches across the mortgage industry, overwhelming lenders and servicers whose cybersecurity measures can’t keep up. With major companies already hit and regulation lagging behind, experts warn the sector—now considered critical infrastructure—must rapidly upgrade protections, collaborate on threat intelligence, and improve AI governance before the risks escalate further.

Hidden Housing Costs May Become 2026’s Most Dangerous Budget Buster

Escrow payments are quietly surging across the country as property taxes and insurance premiums spike—pushing many homeowners toward delinquencies and even foreclosure. New data from Cotality shows the sharpest increases hitting the South and Midwest, with Florida among the hardest‑hit states. Even with fixed mortgage rates, rising escrow requirements are driving monthly payments higher and threatening affordability heading into 2026.

Milwaukee’s Commercial Real Estate Market Is Turning the Corner

Milwaukee entered 2025 with renewed momentum, posting its strongest commercial real estate sales volume in three years. After a period of uncertainty and high capital costs, investors are returning with a sharper focus on quality assets, realistic pricing, and reliable cash flow. Activity is increasing across industrial, office, multifamily, and retail sectors, signaling a broad-based recovery fueled by stabilizing interest rates and improved market confidence.

Title Insurance Leaders Lean Into Tech, Efficiency, and Resilience for 2026

As 2026 approaches, the title insurance industry is navigating a complex mix of market recovery, rising fraud threats, and sweeping regulatory changes. Industry leaders say the path forward centers on smarter technology, leaner operations, and stronger support for title agents. With AI-driven workflows, enhanced fraud prevention, and new compliance demands—including FinCEN’s expanded Geographic Targeting Orders—companies like Stewart and First American are reshaping how title work gets done. For real estate and mortgage professionals, the year ahead promises more automation, heightened standards, and major opportunities for those who stay ahead of the curve.

Technology and the Future of Real Estate: Innovation Reshaping 2025

The real estate industry is undergoing a major transformation in 2025 as advancements in AI, proptech, blockchain, and data intelligence redefine how properties are marketed, valued, financed, and experienced. From instant digital valuations and immersive virtual tours to tokenized investments and predictive analytics, technology is reshaping every stage of the real estate lifecycle. Professionals who embrace these innovations—while maintaining the human expertise clients still rely on—will lead the next era of the industry.